Almirall SA (LBTSF)
15.35
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Almirall Price to Book Value : 1.910 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.910 |
| October 08, 2026 | 1.910 |
| October 07, 2026 | 1.910 |
| October 06, 2026 | 1.910 |
| October 05, 2026 | 1.910 |
| October 02, 2026 | 1.910 |
| October 01, 2026 | 1.910 |
| September 30, 2026 | 1.910 |
| September 29, 2026 | 1.910 |
| September 28, 2026 | 1.910 |
| September 25, 2026 | 1.910 |
| September 24, 2026 | 1.910 |
| September 23, 2026 | 1.910 |
| September 22, 2026 | 1.910 |
| September 21, 2026 | 1.910 |
| September 18, 2026 | 1.910 |
| September 17, 2026 | 1.910 |
| September 16, 2026 | 1.910 |
| September 15, 2026 | 1.910 |
| September 14, 2026 | 1.910 |
| September 11, 2026 | 1.910 |
| September 10, 2026 | 1.910 |
| September 09, 2026 | 1.910 |
| September 08, 2026 | 1.910 |
| September 04, 2026 | 1.910 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.910 |
| September 02, 2026 | 1.910 |
| September 01, 2026 | 1.910 |
| August 31, 2026 | 1.910 |
| August 28, 2026 | 1.910 |
| August 27, 2026 | 1.910 |
| August 26, 2026 | 1.910 |
| August 25, 2026 | 1.910 |
| August 24, 2026 | 1.910 |
| August 21, 2026 | 1.910 |
| August 20, 2026 | 1.910 |
| August 19, 2026 | 1.910 |
| August 18, 2026 | 1.910 |
| August 17, 2026 | 1.910 |
| August 14, 2026 | 1.910 |
| August 13, 2026 | 1.910 |
| August 12, 2026 | 1.910 |
| August 11, 2026 | 1.910 |
| August 10, 2026 | 1.910 |
| August 07, 2026 | 1.910 |
| August 06, 2026 | 1.910 |
| August 05, 2026 | 1.910 |
| August 04, 2026 | 1.910 |
| August 03, 2026 | 1.910 |
| July 31, 2026 | 1.910 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 4.289 |
| AstraZeneca PLC | 10.43 |
| ANI Pharmaceuticals, Inc. | 2.842 |
| Corcept Therapeutics, Inc. | 18.53 |
| Veru, Inc. | 1.478 |
Price to Book Value Related Metrics
| PE Ratio | 48.03 |
| PS Ratio | 2.466 |
| Price to Free Cash Flow | 33.30 |
| Price | 15.35 |
| Earnings Yield | 2.08% |
| Market Cap | 3.343B |
| Operating PE Ratio | 29.49 |
| Normalized PE Ratio | 49.26 |